Gazyva Infusion Reaction Investigation
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib
- Status
- COMPLETED
- Phase
- N/A
Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL
- Status
- COMPLETED
- Phase
- PHASE1
Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Ibrutinib and PD-1 Blockade in High Risk Lymphocytic Leukemia
- Status
- TERMINATED
- Phase
- PHASE2
Venetoclax and Ibrutinib in Treating in Participants With Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evaluation of Human Immune Responses Vaccination in Patients With Lymphoma
- Status
- RECRUITING
- Phase
- N/A
Chronic Lymphocytic Leukemia Responds to Dermal Chelation
- Status
- UNKNOWN
- Phase
- NA
A Study Of The Selective PKC-β Inhibitor MS- 553
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of BNC105P Combined With Ibrutinib
- Status
- COMPLETED
- Phase
- PHASE1
Daratumumab and Ibrutinib in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
- Status
- WITHDRAWN
- Phase
- PHASE2
Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product
- Status
- TERMINATED
- Phase
- N/A
A Prognostic Tool for Early Stage CLL
- Status
- COMPLETED
- Phase
- N/A
Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase I/II Study of Venetoclax or Lenalidomide in Combination With Ublituximab and Umbralisib in Subjects With Relapsed or Refractory CLL/SLL and NHL
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Long-term Follow-up Study of Patients Receiving CAR-T Cells
- Status
- RECRUITING
- Phase
- N/A
Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- N/A